Sedimentation Toxin Activity Assay for Active Inactive Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and quantifying the activity of toxins like Ricin, Shiga-like toxins, and Staphylococcal enterotoxin B are either qualitative, labor-intensive, or time-consuming, lacking the ability to differentiate between active and inactive toxins, which is crucial for accurate diagnostic and therapeutic assessment in bioterrorism scenarios.
Innovation Solution
The development of microfluidic systems and assays that utilize sedimentation to separate and detect active toxins by forming complexes with labeled enzymes on sedimentation particles, which are then concentrated through a density medium, allowing for the detection of depurination activity indicative of toxin activity, enabling rapid and quantitative analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional qualitative toxin detection tests are used, then presence or absence of toxins can be determined, but activity status (active vs inactive) cannot be distinguished
Solution Approach 1:
The patent introduces an intermediary enzyme (e.g., AP endonuclease) that specifically binds to the modified nucleic acid substrate after toxin-mediated depurination. This intermediary converts the subtle chemical change (depurination) into a detectable signal through enzyme-substrate binding, enabling activity differentiation without requiring complex equipment.
Solution Approach 2:
The patent replaces complex mechanical/physical systems (mass spectrometry, HPLC) with a biochemical detection system based on enzyme-substrate binding and sedimentation. This substitution maintains measurement precision for toxin activity while dramatically simplifying the device requirements and enabling portability.
2Measurement precision
If cell-free translation assays or cytotoxicity assays are used for quantitative toxin activity determination, then toxin activity can be measured, but the processes are labor-intensive and time-consuming
Solution Approach 1:
The patent segments the complex cellular machinery of traditional assays into discrete, simplified components: a synthetic nucleic acid substrate containing the specific target sequence, a purified intermediary enzyme, and a detection system. This segmentation eliminates the need for complex cell extracts or live cultures while maintaining quantitative measurement capability, thereby increasing throughput.
Solution Approach 2:
The patent performs preliminary preparation of the nucleic acid substrate with the specific vulnerable sequence before toxin exposure. This pre-prepared substrate is ready for immediate toxin interaction, eliminating the need for complex cellular preparation steps and enabling rapid quantitative assessment of toxin activity.
3Measurement precision
If mass spectrometry or HPLC-ESI-MS is used for toxin detection, then quantitative analysis can be performed, but background noise and reduced sensitivity occur due to interfering components
Solution Approach 1:
The patent extracts only the specific vulnerable sequence from the complex nucleic acid background and incorporates it into a synthetic substrate. This extraction isolates the toxin's specific target from all other interfering components in the sample, allowing detection without background noise while maintaining sensitivity.
Solution Approach 2:
The patent creates a localized detection system where the intermediary enzyme binds specifically to the toxin-modified substrate at a defined location. This local binding event concentrates the detection signal at the site of toxin action, enhancing sensitivity without requiring the entire sample to be free of interfering components.
4Loss of time
If rapid detection tests are used, then detection time is reduced to 1-2 hours, but only qualitative information is provided without activity data
Solution Approach 1:
The patent implements a continuous detection process where the intermediary enzyme remains bound to the modified substrate, allowing the same system to provide both rapid qualitative detection (presence of binding) and quantitative activity assessment (amount of binding). This continuous signal maintains information完整性 while enabling rapid results.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the sensitive and rapid detection and quantification of active toxins, improving sensitivity and reducing the need for amplification, while also distinguishing between active and inactive toxins, facilitating more effective diagnostic and therapeutic strategies.
Implementation Method 1
The sample fluid is provided to a detection region, and sedimentation forces are used to transport the sedimentation particles through a density medium to a detection location
Implementation Method 2
sedimentation forces are used to transport the sedimentation particles through a density medium to a detection location
Implementation Method 3
The sample fluid is provided to a detection region, and sedimentation forces are used to transport the sedimentation particles
Data Source
AI summary
Embodiments of the present invention are directed toward devices, system and method for conducting toxin activity assay using sedimentation. The toxin activity assay may include generating complexes which bind to a plurality of beads in a fluid sample. The complexes may include a target toxin and a labeling agent, or may be generated due to presence of active target toxin and/or labeling agent designed to be incorporated into complexes responsive to the presence of target active toxin. The plurality of beads including the complexes may be transported through a density media, wherein the density media has a lower density than a density of the beads and higher than a density of the fluid sample, and wherein the transporting occurs, at least in part, by sedimentation. Signal may be detected from the labeling agents of the complexes.